miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Open Access
- 14 October 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 19 (20) , 5602-5612
Abstract
Purpose: The purpose of this study was to investigate the clinicopathologic significance and potential role of miR-200b and miR-200c in the development and progression of gastric cancer. Experimental Design: We examined miR-200b and miR-200c expression in 36 paired normal and stomach tumor specimens, as well as gastric cancer cell lines, by quantitative real-time PCR. In addition, miR-200b and miR-200c were detected by ISH using gastric cancer tissue microarrays, and the association between miR-200b and miR-200c levels and clinicopathologic factors and prognosis were analyzed. A luciferase assay was conducted for target evaluation. The functional effects of miR-200b and miR-200c on gastric cancer cells were validated by a cell proliferation assay and cell invasion and migration assays. Results: miR-200b and miR-200c were downregulated in the gastric cancer specimens and cell lines tested. miR-200b and miR-200c levels were significantly correlated with the clinical stage, T stage, lymph node metastasis, and survival of patients. Ectopic expression of miR-200b and miR-200c impaired cell growth and invasion. In addition, when overexpressed, miR-200b and miR-200c commonly directly targeted DNMT3A, DNMT3B, and SP1 (a transactivator of the DNMT1 gene), which resulted in marked reduction of the expression of DNA methyltransferases DNMT1, DNMT3A, and DNMT3B at the protein level. This effect, in turn, led to a decrease in global DNA methylation and reexpression of p16, RASS1A1, and E-cadherin via promoter DNA hypomethylation. Conclusion: Our findings suggest that miR-200b and miR-200c, as valuable markers of gastric cancer prognosis, may be a promising approach to human gastric cancer treatment. Clin Cancer Res; 19(20); 5602–12. ©2013 AACR.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene familyInternational Journal of Cancer, 2013
- The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in GliomasCurrent Cancer Drug Targets, 2013
- Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer CellsPLOS ONE, 2012
- Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and InvasionMolecular Therapy, 2012
- MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1Clinical and Experimental Medicine, 2012
- The Duality of OncomiR Addiction in the Maintenance and Treatment of CancerThe Cancer Journal, 2012
- Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaActa Neuropathologica, 2012
- miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate CellsJournal of Biological Chemistry, 2011
- miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinomaJournal of Cell Science, 2011
- MicroRNA in Cancer PrognosisNew England Journal of Medicine, 2008